This episode is shared from Mayo Clinic Q&A and was recorded in November, 2021

Guest:  Gregory A. Poland, M.D. (@drgregpoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

Cold weather, increased travel, waning immunity and the potential for new variants may serve up the perfect recipe for a holiday COVID-19 surge, according to Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group.  

"I have consistently said what's very likely to happen as we get to the cooler weather and see the trends in travel is that we will have another surge," says Dr. Poland. "We're in this unusual situation where the pandemic is actually getting worse because humans don't want to believe that the pandemic is just as important now as it was a year ago."

In this Mayo Clinic Q&A podcast, Dr. Poland answers several listener questions and talks more about being vigilant against COVID-19 as the U.S. heads into a second winter with this coronavirus. He also addresses the recent news that wild deer have shown evidence of COVID-19 infection and what that might mean in the battle to eliminate the disease. 

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health

Guests: Gina A. Suh, M.D.

Host: Denise M. Dupras, M.D., Ph.D.

What is Phage Therapy? When was it discovered? Where is it used? We know about antibiotics, antifungals, and antivirals, but this is a whole new world! Have no fear, this episode is here from the Genes & Your Health miniseries to help demystify all there is to know about Phages.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Monique A. Freund, M.D.

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Hyperlipidemia is one of the major risk factors for cardiovascular disease. It’s known that a combination of lifestyle changes and pharmacologic therapy has proven effective in reducing the complications of cardiovascular disease. Despite this, it’s estimated that less than 35% of those patients with hyperlipidemia are adequately managed. Why aren’t we doing a better job at managing this major public health problem? In this podcast, we’ll be speaking with Monique A. Freund, M.D., a cardiologist at Mayo Clinic. We’ll discuss how to optimize management of hyperlipidemia, which lifestyle changes are beneficial, when to use pharmacologic therapy and how to manage patients with statin intolerance.

Specific topics:

• Relative importance of elevated LDLc, low HDLc and elevated triglycerides

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health

Guests: Christopher (Chris) A. Aakre (@ChrisAakreMD), M.D.; Bradley J. Erickson, M.D., Ph.D.

Host: Denise M. Dupras, M.D., Ph.D.

Artificial Intelligence has begun being utilized in Radiology. In fact, it was boldly predicted that Radiology would become an obsolete profession as a result! How has it altered this practice? How will it alter our practices moving forward? Join this episode of our Genes & Your Health miniseries from the Center of Individualized Medicine to learn these answers and more!

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Amir R. Khan, M.D.

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

External eye disorders are commonly seen in a primary care provider’s office, yet very few of us have ever had any formal training in ophthalmology. Fortunately, most of the external eye problems are relatively benign, though not all. It’s important to be able to recognize these conditions since some may be associated with a variety of systemic diseases. In this podcast, Amir Khan, M.D., an ophthalmologist at Mayo Clinic, joins Dr. Chutka to discuss how to recognize commonly seen external eye conditions. Links to specific topics below include additional information and images for most of the covered conditions.

Specific topics:

• Viral versus bacterial conjunctivitis: https://www.mayoclinic.org/diseases-conditions/pink-eye/symptoms-causes/syc-20376355

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in November  3, 2021

Guest:  Elie F. Berbari, M.D.

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

In anticipation of more COVID-19 vaccine approvals this week, Dr. Elie Berbari, chair of the Division of Infectious Diseases at Mayo Clinic, says it's good news that younger children will now have more protection against COVID-19.

"It's important that we reach a very high level of vaccination rates to achieve kind of a wall of immunity that could prevent transmission and prevent us from these repeated peaks that we've been dealing with over the last year and a half during this pandemic," says Dr. Berbari. 

In this Mayo Clinic Q&A podcast, Dr. Berbari also talks about the rare cases of myocarditis and how the Food and Drug Administration is monitoring those cases. Dr. Berbari also addresses additional COVID-19 vaccine doses for immunocompromised people, the importance of masking, even if vaccinated, and he answers a number of listener questions.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health

Guests: Megan A. Allyse, Ph.D. (@MAllyse); Jennifer (Jenny) L. Anderson, M.S., CGC; Radhika Dhamija, M.B.B.S. (@NeurogenesDr)

Host: Denise M. Dupras, M.D., Ph.D.

Genetic testing is increasingly becoming mainstream. Not only is it first-line testing for many different indications, but we have begun seeing an increase in predictive genomics for healthy patients as well. How can your practice prepare for what is here and what is to come? Tune in to this episode of the Genes & Your Health miniseries from the Center for Individualized Medicine to find out.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Rozalina G. McCoy, M.D., M.S. (@RozalinaMD)

Host: Amit K. Ghosh, M.D. (@AmitGhosh006)

Diabetic research starts with understanding contemporary treatment practices (overtreatment and undertreatment, misuse or underuse of glucose-lowering medications, comparative effectiveness of different diabetes medications), the resulting impact on patient health and the disparities in both treatment practices and outcomes. In this episode Rozalina McCoy, M.D., M.S., associate professor of medicine and consultant in the Division of Community Internal Medicine at Mayo Clinic’s Rochester campus, joins us to discuss developing care delivery models that support high-quality, evidence-based, patient-centered, and equitable diabetes care.

Additional resources:

• McCoy RG, Galindo RJ, Swarna KS, et al. Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020. JAMA Netw Open. 2021;4(9):e2123471. doi:1001/jamanetworkopen.2021.23471

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health

Guest: Iftikhar J. Kullo, M.D. (@iftikhar_kullo)

Host: Denise M. Dupras, M.D., Ph.D.

What is familial hypercholesterolemia? Who should be tested for it? Are there genetic variants that are associated with cardiovascular diseases? How young do we start screening? This installment of the Genes & Your Health miniseries from the Center for Individualized Medicine is here to help answer these questions and more!

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Sophie J. Bakri, M.D.

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Macular degeneration is the most common cause of vision loss in individuals over the age of 50. The loss of central vision from macular degeneration can result in significant lifestyle changes in patients. They may no longer be able to read, write or drive. In this podcast, we’ll discuss macular degeneration with Sophie Bakri, M.D., an ophthalmologist at Mayo Clinic. She’ll review the two types and pathology of macular degeneration, its presentation, risk factors and preventive strategies, and new treatments on the horizon.

Specific topics:

• Pathologic changes in macular degeneration

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.